Jean Duvall
Direktor/Vorstandsmitglied bei ONDINE BIOMEDICAL INC.
Vermögen: 13 994 $ am 30.04.2024
Aktive Positionen von Jean Duvall
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ONDINE BIOMEDICAL INC. | Direktor/Vorstandsmitglied | 07.12.2021 | - |
Independent Dir/Board Member | 07.12.2021 | - | |
ROQUEFORT THERAPEUTICS PLC | Direktor/Vorstandsmitglied | 05.04.2022 | - |
Ferring International Center SA
Ferring International Center SA Pharmaceuticals: MajorHealth Technology Ferring International Center SA develops, manufactures and markets products in the fields of urology, gynaecology and obstetrics. It also specializes in the fields of gastroenterology and endocrinology. The company was founded in 1950 and is headquartered in Saint-Prex, Switzerland. | Direktor/Vorstandsmitglied | - | - |
General Counsel | 01.11.2006 | - | |
Unternehmenssekretär | 01.11.2006 | - | |
Repronovo SA | Direktor/Vorstandsmitglied | - | - |
Vorstandsvorsitzender | - | - | |
Gründer | - | - |
Karriereverlauf von Jean Duvall
Ehemalige bekannte Positionen von Jean Duvall
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Ferring Research Ltd. | Direktor/Vorstandsmitglied | - | - |
International School of Lausanne | Direktor/Vorstandsmitglied | - | - |
Ferring Properties SA | Direktor/Vorstandsmitglied | - | - |
Gliotherapy Ltd. | Direktor/Vorstandsmitglied | - | - |
Kuopio Center For Gene & Cell Therapy Kct oy | Direktor/Vorstandsmitglied | - | - |
░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░ | - | - | |
░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░ ░░░░░░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - | |
░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░ ░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░ | - | - | |
░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - | |
░░░░░░░░ ░░░░ | ░░░░░░░░ | - | - |
░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
░░░░ ░░░░░ ░░░ | ░░░░░░░ ░░░░░░░ | - | - |
Ausbildung von Jean Duvall
Case Western Reserve University | Undergraduate Degree |
The Ohio State University | Graduate Degree |
Statistik
International
Schweiz | 7 |
Vereinigtes Königreich | 7 |
Vereinigte Staaten | 5 |
Operativ
Director/Board Member | 18 |
Founder | 3 |
General Counsel | 2 |
Sektoral
Health Technology | 11 |
Consumer Services | 3 |
Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
ONDINE BIOMEDICAL INC. | Health Technology |
ROQUEFORT THERAPEUTICS PLC | Health Technology |
Private Unternehmen | 18 |
---|---|
Ferring International Center SA
Ferring International Center SA Pharmaceuticals: MajorHealth Technology Ferring International Center SA develops, manufactures and markets products in the fields of urology, gynaecology and obstetrics. It also specializes in the fields of gastroenterology and endocrinology. The company was founded in 1950 and is headquartered in Saint-Prex, Switzerland. | Health Technology |
Repronovo SA | |
Elan Corp. Plc
Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Elan Corp. Plc is a neuroscience focused biotechnology company. The company engages in research, development, and commercial activities for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease and autoimmune diseases, including multiple sclerosis. It was founded in December 1969 and is headquartered in Dublin, Ireland. | Health Technology |
Trizell Ltd.
Trizell Ltd. BiotechnologyHealth Technology Trizell Ltd. engages in research and experimental development on biotechnology. The company was founded on April 14, 1997 and is headquartered in Chinnor, the United Kingdom. | Health Technology |
Ferring Laboratories Ltd.
Ferring Laboratories Ltd. Pharmaceuticals: MajorHealth Technology Part of Ferring Holding SA, Ferring Laboratories Ltd. is a British pharmaceutical company that develops, manufactures, and markets pharmaceutical products. The company is based in Middlesex, UK and was founded in 1980. | Health Technology |
FerGene, Inc.
FerGene, Inc. BiotechnologyHealth Technology FerGene, Inc. provides gene therapy solutions to urologists. The company is headquartered in Cambridge, MA. | Health Technology |
Trizell Holding SA | |
Ferring Pharmaceuticals, Inc.
Ferring Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ferring Pharmaceuticals, Inc. develops and markets fertility and endocrinology products. Its products include Bravelle, Repronex, Novarel, Acthrel and Desmopressin Acetate. The company's products are used in treatment of osteoarthritis, prostate cancer, and other infertility related diseases. Ferring Pharmaceuticals was founded in 1951 and is headquartered in Parsippany, NJ. | Health Technology |
CPSI Holdings Ltd. | |
CPSI Scotland Ltd.
CPSI Scotland Ltd. Financial ConglomeratesFinance Part of CPSI Holdings Ltd., CPSI Scotland Ltd. is a financial services provider. The company is based in East Kilbride, UK. CPSI Scotland was founded in 2011. | Finance |
Ferring Pharmaceuticals SA
Ferring Pharmaceuticals SA BiotechnologyHealth Technology Ferring Pharmaceuticals SA develops and markets biopharmaceutical products. It provides products in the fields of reproductive health, urology, gastroenterology, endocrinology, and osteoarthritis. The company was founded by Frederik Paulsen Sr in 1950 and is headquartered in Saint-Prex, Switzerland. | Health Technology |
FinVector Oy
FinVector Oy Pharmaceuticals: MajorHealth Technology Part of Ferring Ventures, FinVector Oy is a Finnish biopharmaceutical company that specializes in manufacturing viral-based gene therapy products. The company is based in Kuopio, Finland, and has extensive experience in cgmp manufacturing. FinVector employs hundreds of highly qualified professionals from over 40 different countries and works on cutting-edge biopharmaceuticals. It has invested in building state-of-the-art gmp facilities for viral vector platforms. The company was founded in 1993 by Seppo Ylä-Herttuala, and the CEO is Giuseppe Carloni. | Health Technology |
Amzell BV | |
Gliotherapy Ltd. | |
Kuopio Center For Gene & Cell Therapy Kct oy | |
International School of Lausanne | |
Ferring Properties SA | |
Ferring Research Ltd. |
- Börse
- Insiders
- Jean Duvall
- Erfahrung